000403 logo

Pacific Shuanglin Bio-pharmacy
000403

Last Price

Balance Sheet

Assets
Metric199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024LTM
CN¥1.853BCN¥1.604BCN¥1.235B
CN¥635.108MCN¥716.842MCN¥775.975M
CN¥0.909BCN¥1.233BCN¥1.731B
CN¥26.736MCN¥23.011MCN¥31.3M
CN¥2.169MCN¥2.02MCN¥2.049M
CN¥3.426BCN¥3.579BCN¥3.775B
CN¥1.554BCN¥1.999BCN¥2.063B
CN¥2.895BCN¥2.925BCN¥2.982B
-CN¥-276.702MCN¥606.283M
CN¥49.036MCN¥29.425MCN¥33.063M
CN¥706.704MCN¥990.729MCN¥115.029M
CN¥5.204BCN¥5.667BCN¥5.8B
---
CN¥8.63BCN¥9.246BCN¥9.575B
Liabilities
Metric199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024LTM
CN¥596.324MCN¥603.059MCN¥166.435M
--CN¥28.762M
CN¥250.571MCN¥310.489MCN¥826.066M
---
CN¥71.054MCN¥48.617M-
--CN¥3.147M
CN¥75.3MCN¥43.424MCN¥262.161M
CN¥0.922BCN¥0.957BCN¥1.287B
CN¥174.602MCN¥284.617MCN¥197.264M
CN¥21.477MCN¥18.605M-
CN¥35.603MCN¥26.843MCN¥37.079M
CN¥24.256MCN¥14.125MCN¥12.789M
CN¥9MCN¥9MCN¥0.632M
CN¥286.416MCN¥371.795MCN¥260.454M
---
CN¥1.209BCN¥1.329BCN¥1.547B
Equity
Metric199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024LTM
CN¥-43.173M--
---
CN¥733.001MCN¥731.075MCN¥950.397M
CN¥1.836BCN¥2.276BCN¥2.374B
CN¥4.749BCN¥4.714B-
CN¥0BCN¥0.204BCN¥4.702B
CN¥154.633MCN¥203.612M-
CN¥7.429BCN¥7.925BCN¥8.026B
CN¥-6.785MCN¥-7.148MCN¥-6.782M
CN¥7.422BCN¥7.918BCN¥8.019B
CN¥8.63BCN¥9.246BCN¥9.575B
Other
Metric199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024LTM
CN¥0.423BCN¥0.006BCN¥1.265B
CN¥0.468BCN¥0.632BCN¥1.036B
CN¥-933.33MCN¥-688.809MCN¥460.118M

Balance Sheet Composition

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.